82
Participants
Start Date
November 30, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Misoprostol + referral
800 mcg of sublingual misoprostol (four tablets of 200 mcg misoprostol) + standard of care (referral to higher level care)
Placebo + referral
Placebo (4 tablets resembling misoprostol) + standard of care (referral to higher level care)
Prinary Health Units, Etay El Barood and Kafr El Dawar Districts
Ministry of Health and Population, Egypt
OTHER_GOV
El Galaa Teaching Hospital
OTHER
Alexandria University
OTHER
Gynuity Health Projects
OTHER